Vice Chair for Quality and Safety
Division Vice Chief of Internal Medicine
Director of Critical Care
Professor of Medicine
To see if Christian Sandrock is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Emerging Infectious Diseases
Outbreak Management
Sepsis
Critical Care Medicine
UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817
Phone: 800-2-UCDAVIS (800-282-3284)
Dr. Sandrock believes in a patient-driven and centered approach that focuses on holistic care, including family support, alternative therapies, religion, lifestyle practices, cultural practices and other modalities in conjunction with conventional therapies.
Dr. Sandrock has clinical interests in respiratory infections, community-acquired and viral pneumonia, and ICU-acquired infections. His research interests include emerging infectious diseases at the animal and human interface, particularly respiratory infections such as avian influenza, SARS, and other diseases acquired by humans.
His research interests include emerging infectious diseases at the animal and human interface, particularly respiratory infections such as avian influenza, SARS, and other diseases acquired by humans.
B.A., Rutgers University, New Brunswick NJ 1992
M.D., Georgetown University School of Medicine, Washington DC 1996
M.P.H., University of Lund, Lund, Sweden 2005
Internal Medicine, UC Davis Medical Center, Sacramento CA 1996-1997
Internal Medicine, UC Davis Medical Center, Sacramento CA 1997-1999
Infectious Diseases & Pulmonary and Critical Care, UC Davis Medical Center, Sacramento CA 1999-2005
Diamond Doc Award, 2021
Certificate of Appreciation Yolo County Health Department Mass Vaccination Clinic Drill, 2004
Outstanding Fellow, 2003
Betty Ford Center Professional in Residence, 1993
Pellegrini Scholarship of Swiss Benevolent Society, 1992, 1993, 1994, 1995, 1996
LoVecchio F, Schranz J, Alexander E, Mariano D, Meads A, Sandrock C, Moran GJ, Giordano PA. Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial. J Emerg Med. 2021 Jun;60(6):781-792. doi:10.1016/j.jemermed.2021.02.001. Epub 2021 Mar 14. PMID:33731270.
Bays DJ, Nguyen MH, Cohen SH, Waldman S, Martin CS, Thompson GR, Sandrock C, Tourtellotte J, Pugashetti JV, Phan C, Nguyen HH, Warner GY, Penn BH. Investigation of nosocomial SARS-CoV-2 transmission from two patients to healthcare workers identifies close contact but not airborne transmission events. Infect Control Hosp Epidemiol. 2021 Sep;42(9):1046-1052. doi:10.1017/ice.2020.321. Epub 2020 Jul 3. PMID:32618530.
Sandrock C, Aziz SR. Travel/Tropical Medicine and Pandemic Considerations for the Global Surgeon. Oral Maxillofac Surg Clin North Am. 2020 Aug;32(3):407-425. doi:10.1016/j.coms.2020.05.001. Epub 2020 May 8. PMID:32473858.
Theriault N, Tillotson G, Sandrock CE. Global travel and Gram-negative bacterial resistance; implications on clinical management. Expert Rev Anti Infect Ther. 2021 Feb;19(2):181-196. doi:10.1080/14787210.2020.1813022. Epub 2020 Sep 9. PMID:32815412.
Sharma R, Sandrock CE, Meehan J, Theriault N. Community-Acquired Bacterial Pneumonia-Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin. Clin Drug Investig. 2020 Oct;40(10):947-960. doi:10.1007/s40261-020-00953-z. Erratum in: Clin Drug Investig. 2021 Feb;41(2):197. PMID:32889706.
Alexander E, Goldberg L, Das AF, Moran GJ, Sandrock C, Gasink LB, Spera P, Sweeney C, Paukner S, Wicha WW, Gelone SP, Schranz J. Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial. JAMA. 2019 Nov 5;322(17):1661-1671. doi:10.1001/jama.2019.15468. PMID:31560372.
Najafi S, Sandrock C. Hospitalized Patients with Acute Pneumonia. Hosp Med Clin. 2017 Oct;6(4):456-469. doi:10.1016/j.ehmc.2017.05.012. Epub 2017 Sep 15. PMID:32288999.
Nguyen LP, Sriratanaviriyakul N, Sandrock C. A Rare but Reversible Cause of Hematemesis. Case Reports in Critical Care. 2016;2370109. doi:10.1155/2016/2370109.
Albertson TE, Harper R, Murin S, Sandrock C. Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Prefer Adherence. 2015 Feb 2;9:235-42. doi:10.2147/PPA.S71535. PMID:25673975.
Aksenov AA, Sandrock CE, Zhao W, Sankaran S, Schivo M, Harper R, Cardona CJ, Xing Z, Davis CE. Cellular scent of influenza virus infection. Chembiochem. 2014 May 5;15(7):1040-8. doi:10.1002/cbic.201300695. Epub 2014 Apr 9. PMID:24719290.